Overview Fundamentals API Earnings EOD API Sample Code Pricing

Thiogenesis Therapeutics Corp. (TTI V) stock market data APIs

C$0.45 -0.34(-43%) as of July 26, 2024
Price chart is built with Anychart

Thiogenesis Therapeutics, Corp., a biopharmaceutical company, develops thiol-active therapeutic compounds to treat unmet pediatric medical needs. The company's lead product candidate comprises TTI-0102, a prodrug that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke, other mitochondrial diseases, Rett syndrome, and pediatric non-alcoholic fatty liver diseases. Thiogenesis Therapeutics, Corp. is headquartered in Toronto, Canada.

Thiogenesis Therapeutics Corp. Financial Data Overview

0.83
0.45
-
0.33
0.49
0.6-1.06
35 487 K
45 496 K
0
0.588
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TTI',
Type: 'Common Stock',
Name: 'Thiogenesis Therapeutics Corp.',
Exchange: 'V',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Thiogenesis Therapeutics Corp. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -0.12
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Thiogenesis Therapeutics Corp. Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Thiogenesis Therapeutics Corp. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com